Update on

Update on

European Update on SPC’s

There have been a lot of developments in the interpretation of the legislation around SPCs. As for the 'protected by the basic patent' requirement, many uncertainties, in particular for SPC cases wherein the product is a non-disclosed species of the claimed genus, which are extremely difficult to oversee for those not frequently involved in SPC practice. There seems to be a general consensus that clarification from future cases, either with national courts or with the Court of Justice, is much needed.

In this article, Jaap Mannaerts and Mari Korsten, Partners at NLO examine in detail product disclosure and identification as well as Royalty Pharma rulings in relation to product combination SPC's.

Download the report below.

Enter your details below to download this white paper for free. A download link will appear below. 

    I agree to the the terms set out with Insight IP’s Privacy Policy
    I agree


    Insight IP Ltd,
    Blackwell House,
    Guildhall Yard,
    London, EC2V 5AE
    T: +44 (0) 207 846 0283

    Copyright © 2021 All Rights Reserved. Web Design by Intuitive Web Design